Geoffrey Nicholas Vernon
Directeur Général chez Ziggus Holdings Ltd.
Profil
Geoffrey Nicholas Vernon is currently the Executive Chairman & Chief Executive Officer at Ziggus Holdings Ltd.
He is also the Chairman-Supervisory Board at XL TechGroup, Inc., a Non-Executive Director at Cornwall Farmers Ltd., and a Member at Royal Pharmaceutical Society of Great Britain.
In the past, he served as the Deputy Chairman-Supervisory Board at MorphoSys AG, Non-Executive Chairman at Advanced Medical Solutions Group Plc, Chairman-Sueprvisory Board at MedPharm Ltd., Non-Executive Chairman at Veryan Medical Ltd., Chairman at Apitope Technology (Bristol) Ltd., Chairman-Supervisory Board at Spark Therapeutics Ireland Ltd., and Non-Executive Director at TyraTech, Inc. He was also an Executive Director at Rothschild Asset Management Ltd., a Product Manager at Baxter Healthcare Corp., a Manager-Commercial Development at Schering Health Care Ltd., a Hospital Pharmacist at National Health Service, and a Partner at Venture Capital Group Advent Ltd.
Additionally, he served as a Manager-Business Development at Ciba-Geigy Pharmaceuticals.
Postes actifs de Geoffrey Nicholas Vernon
| Sociétés | Poste | Début |
|---|---|---|
XL TechGroup, Inc.
 XL TechGroup, Inc. Chemicals: AgriculturalProcess Industries XL TechGroup, Inc. invests in the biotech, ecotech and medtech sectors. It also develops and commercializes proprietary insecticide and parasiticide products including non-toxic, pesticides, and anti-parasitic compounds for use in agriculture, horticulture, functional foods, healthcare, and veterinary applications. The firm involves in commercializing new technologies to grow and harvest oil from algae, an alternative to petroleum oil. The company was founded in 1993 and is located in Melbourne, FL. | Président | - |
Ziggus Holdings Ltd.
 Ziggus Holdings Ltd. Agricultural Commodities/MillingProcess Industries Ziggus Holdings Ltd. operates cattle and sheep farms. Geoffrey Nicholas Vernon has been the CEO of the British company since 1998. | Directeur Général | 01/01/1998 |
Royal Pharmaceutical Society of Great Britain
 Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Corporate Officer/Principal | 01/06/2010 |
Cornwall Farmers Ltd.
 Cornwall Farmers Ltd. Agricultural Commodities/MillingProcess Industries Cornwall Farmers Ltd. operates as an agricultural farmer’s cooperative that sells products and services. The firm provides farming and pet supplies, products for horse and rides. It offers livestock resources, feeds, arable supplies, ariat, baileys, champion, horseware, cesar, whiskas, pedigree and feed for poultry, sheep, pigs and cattle. The company was founded in 1920 and is headquartered in Truro, the United Kingdom. | Directeur/Membre du Conseil | 13/03/2013 |
Anciens postes connus de Geoffrey Nicholas Vernon
| Sociétés | Poste | Fin |
|---|---|---|
| MORPHOSYS AG | Directeur/Membre du Conseil | 08/05/2015 |
| ADVANCED MEDICAL SOLUTIONS GROUP PLC | Président | 31/12/2010 |
| TYRATECH, INC. | Directeur/Membre du Conseil | 10/05/2010 |
| Rothschild Asset Management Ltd. | Directeur/Membre du Conseil | - |
| Venture Capital Group Advent Ltd. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ADVANCED MEDICAL SOLUTIONS GROUP PLC | Health Technology |
| MORPHOSYS AG | Health Technology |
| Entreprise privées | 15 |
|---|---|
XL TechGroup, Inc.
XL TechGroup, Inc. Chemicals: AgriculturalProcess Industries XL TechGroup, Inc. invests in the biotech, ecotech and medtech sectors. It also develops and commercializes proprietary insecticide and parasiticide products including non-toxic, pesticides, and anti-parasitic compounds for use in agriculture, horticulture, functional foods, healthcare, and veterinary applications. The firm involves in commercializing new technologies to grow and harvest oil from algae, an alternative to petroleum oil. The company was founded in 1993 and is located in Melbourne, FL. | Process Industries |
| Rothschild Asset Management Ltd. | Miscellaneous |
Ziggus Holdings Ltd.
Ziggus Holdings Ltd. Agricultural Commodities/MillingProcess Industries Ziggus Holdings Ltd. operates cattle and sheep farms. Geoffrey Nicholas Vernon has been the CEO of the British company since 1998. | Process Industries |
Spark Therapeutics Ireland Ltd.
 Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland. | Health Technology |
Apitope Technology (Bristol) Ltd.
 Apitope Technology (Bristol) Ltd. Miscellaneous Commercial ServicesCommercial Services Apitope Technology (Bristol) Ltd. is a European biotech company developing therapeutic vaccines for treating autoimmune and allergic diseases, including multiple sclerosis, Type 1 diabetes, Graves' disease, allergies and organ transplant rejection. The team at Apitope is developing potential therapies intended to selectively treat the underlying cause of a range of autoimmune diseases rather than simply treat the disease symptoms or non-specifically suppress the whole immune system. Apitope's approach is based on well-established scientific evidence published in leading scientific journals showing that soluble, synthetic peptides can selectively suppress abnormal immune responses and reinstate the normal immune balance and thereby, tolerance. The firm's strategy is to position itself as a significant player in the therapeutic peptide space and make it a partner of choice for pharmaceutical companies keen to develop disease modifiers for autoimmune conditions. It has a highly experienced senior management team, with a proven track record in discovering and developing innovative compounds. The company's lead product candidate is under investigation for the potential treatment of multiple sclerosis and is currently in Phase I clinical development. It is partnered with Merck-Serono (a division of Merck KGaA, Darmstadt, Germany), one of the leading companies in the development and marketing of MS therapies. | Commercial Services |
Royal Pharmaceutical Society of Great Britain
Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Commercial Services |
Veryan Medical Ltd.
 Veryan Medical Ltd. BiotechnologyHealth Technology Veryan Medical Ltd. develops and commercializes novel vascular stent technology. The firm's products are designed to clinical performance and bio-mechanical performance of stented vessels. The company was founded by Colin G. Caro, Charles Richard Taylor and Paul Burke Gilson in 2003 and is headquartered in Oxford, the United Kingdom. | Health Technology |
| Venture Capital Group Advent Ltd. | |
Cornwall Farmers Ltd.
Cornwall Farmers Ltd. Agricultural Commodities/MillingProcess Industries Cornwall Farmers Ltd. operates as an agricultural farmer’s cooperative that sells products and services. The firm provides farming and pet supplies, products for horse and rides. It offers livestock resources, feeds, arable supplies, ariat, baileys, champion, horseware, cesar, whiskas, pedigree and feed for poultry, sheep, pigs and cattle. The company was founded in 1920 and is headquartered in Truro, the United Kingdom. | Process Industries |
MedPharm Ltd.
 MedPharm Ltd. Miscellaneous Commercial ServicesCommercial Services MedPharm Ltd. provides pharmaceutical research and development services for dermatological, nail, eye, airway, mucosal membrane, and transdermal products. Its drug delivery technologies include MedSpray, a patch-in-a-can aerosol technology for drug delivery in the form of a film to topical/mucosal membranes for immediate or sustained/extended delivery. The company was founded by Andrew G. Muddle in August 1999 and is headquartered in Guildford, the United Kingdom. | Commercial Services |
TyraTech, Inc.
 TyraTech, Inc. Chemicals: SpecialtyProcess Industries TyraTech, Inc. engages in development of non toxic personal care products. The firm also engages in the development, manufacture, marketing, and sale of proprietary insecticide and parasiticide products. It products include insect repellent and equine fly repellent. The company was founded in May 2004 and is headquartered in Morrisville, NC. | Process Industries |
| Schering Health Care Ltd. | |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
National Health Service
 National Health Service Internet Software/ServicesTechnology Services National Health Service provides health care services. It offers hospital services, family doctors, dentists, opticians and pharmacists and local authority health services, community nursing and health care services. The company was founded by Aneurin Bevan on July 5, 1948 and is headquartered in London, the United Kingdom. | Technology Services |
| Ciba-Geigy Pharmaceuticals |
